- VASCEPA ACD: DIGITALWEB PHARMA
- VASCEPA ACD: DIGITALWEB PHARMA
- VASCEPA ACD: DIGITALWEB PHARMA
- VASCEPA ACD: DIGITALWEB PHARMA
- VASCEPA ACD: DIGITALWEB PHARMA
- VASCEPA ACD: DIGITALWEB PHARMA
- VASCEPA ACD: DIGITALWEB PHARMA
- VASCEPA ACD: DIGITALWEB PHARMA
VASCEPA
The BRIEF
Role: ACD, Pharma, Website
Period: 2021-2022
Platform: Print, Digital, Video
Lift: Part of a 360 Campaign
The TEAM
- Travis Hibbis, VP, CD
- Lisa Boosin, ACD
- Anthony Lowe, ACD
- Michelle Johnson, Studio Manager
- Hayden Griffin, Copywriter
- Kerry Goeller, Digital Production Artist
The RUNDOWN
VASCEPA is the first and only FDA-approved medication to lower CV risk in addition to other medications, such as statins, in patients with high triglycerides (≥150 mg/dL) and heart disease or diabetes with other CV risk factors. The exact science of how VASCEPA works in the body is not fully understood, but years of clinical testing have led to proven results.
THE CHARGE
- Managed shareholders from concept through to completion, working with both in-house resources and external vendors
- Provided leadership and professional development to creative staff
- Ensured brand identity, functionality and message consistency across channels
- Evaluated digital creative concepts, copy and art, at pre-determined points and providing direction prior to review by account management
The WORK
